Details for Patent: 8,858,961
✉ Email this page to a colleague
Which drugs does patent 8,858,961 protect, and when does it expire?
Patent 8,858,961 protects ALPHAGAN P and is included in one NDA.
Protection for ALPHAGAN P has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-eight patent family members in nineteen countries.
Summary for Patent: 8,858,961
| Title: | Compositions containing alpha-2-adrenergic agonist components |
| Abstract: | Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose. |
| Inventor(s): | Graham; Richard S. (Irvine, CA), Bakhit; Peter G. (Huntington Beach, CA), Olejnik; Orest (Coto De Caza, CA) |
| Assignee: | Allergan, Inc. (Irvine, CA) |
| Application Number: | 12/482,783 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,858,961 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 8,858,961
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021770-001 | Aug 19, 2005 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,858,961
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 033539 | ⤷ Try a Trial | |||
| Australia | 2001273269 | ⤷ Try a Trial | |||
| Australia | 2005220199 | ⤷ Try a Trial | |||
| Australia | 2005280259 | ⤷ Try a Trial | |||
| Australia | 2011250793 | ⤷ Try a Trial | |||
| Australia | 7326901 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
